Drugmakers are investing early in Africa's middle classes SmartPlanet.com (blog) Non-communicable diseases — like heart disease, lung disorders, diabetes and cancer — are expected to account for 46 percent of all deaths in sub-Saharan Africa by 2030. By 2016, pharmaceutical spending in Africa is expected to reach $30 billion ... |
